CURRENT EYE RESEARCH, cilt.36, ss.1005-1013, 2011 (SCI İndekslerine Giren Dergi)
Aim and scope: To investigate the inhibitory effect of subconjunctival application of VEGF antibodies bevacizumab, ranibizumab, pegaptanib, and HER2 antibody trastuzumab on corneal neovascularization in a rat model of experimental corneal neovascularization.